BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 12418961)

  • 1. Mad4 is regulated by a transcriptional repressor complex that contains Miz-1 and c-Myc.
    Kime L; Wright SC
    Biochem J; 2003 Feb; 370(Pt 1):291-8. PubMed ID: 12418961
    [TBL] [Abstract][Full Text] [Related]  

  • 2. c-Myc creates an activation loop by transcriptionally repressing its own functional inhibitor, hMad4, in young fibroblasts, a loop lost in replicatively senescent fibroblasts.
    Marcotte R; Chen JM; Huard S; Wang E
    J Cell Biochem; 2005 Dec; 96(5):1071-85. PubMed ID: 16167342
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myc represses differentiation-induced p21CIP1 expression via Miz-1-dependent interaction with the p21 core promoter.
    Wu S; Cetinkaya C; Munoz-Alonso MJ; von der Lehr N; Bahram F; Beuger V; Eilers M; Leon J; Larsson LG
    Oncogene; 2003 Jan; 22(3):351-60. PubMed ID: 12545156
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mmip1: a novel leucine zipper protein that reverses the suppressive effects of Mad family members on c-myc.
    Gupta K; Anand G; Yin X; Grove L; Prochownik EV
    Oncogene; 1998 Mar; 16(9):1149-59. PubMed ID: 9528857
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of Myc/Max/Mad network members in adipogenesis: inhibition of the proliferative burst and differentiation by ectopically expressed Mad1.
    Pulverer B; Sommer A; McArthur GA; Eisenman RN; Lüscher B
    J Cell Physiol; 2000 Jun; 183(3):399-410. PubMed ID: 10797315
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mouse Sin3A interacts with and can functionally substitute for the amino-terminal repression of the Myc antagonist Mxi1.
    Rao G; Alland L; Guida P; Schreiber-Agus N; Chen K; Chin L; Rochelle JM; Seldin MF; Skoultchi AI; DePinho RA
    Oncogene; 1996 Mar; 12(5):1165-72. PubMed ID: 8649810
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Repression of p15INK4b expression by Myc through association with Miz-1.
    Staller P; Peukert K; Kiermaier A; Seoane J; Lukas J; Karsunky H; Möröy T; Bartek J; Massagué J; Hänel F; Eilers M
    Nat Cell Biol; 2001 Apr; 3(4):392-9. PubMed ID: 11283613
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kinetics of myc-max-mad gene expression during hepatocyte proliferation in vivo: Differential regulation of mad family and stress-mediated induction of c-myc.
    Mauleon I; Lombard MN; Muñoz-Alonso MJ; Cañelles M; Leon J
    Mol Carcinog; 2004 Feb; 39(2):85-90. PubMed ID: 14750213
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sequential expression of the MAD family of transcriptional repressors during differentiation and development.
    Quéva C; Hurlin PJ; Foley KP; Eisenman RN
    Oncogene; 1998 Feb; 16(8):967-77. PubMed ID: 9519870
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New Myc-interacting proteins: a second Myc network emerges.
    Sakamuro D; Prendergast GC
    Oncogene; 1999 May; 18(19):2942-54. PubMed ID: 10378691
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential effects of the widely expressed dMax splice variant of Max on E-box vs initiator element-mediated regulation by c-Myc.
    FitzGerald MJ; Arsura M; Bellas RE; Yang W; Wu M; Chin L; Mann KK; DePinho RA; Sonenshein GE
    Oncogene; 1999 Apr; 18(15):2489-98. PubMed ID: 10229200
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of Myc and Mad during epidermal differentiation and HPV-associated tumorigenesis.
    Hurlin PJ; Foley KP; Ayer DE; Eisenman RN; Hanahan D; Arbeit JM
    Oncogene; 1995 Dec; 11(12):2487-501. PubMed ID: 8545105
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An alternative pathway for gene regulation by Myc.
    Peukert K; Staller P; Schneider A; Carmichael G; Hänel F; Eilers M
    EMBO J; 1997 Sep; 16(18):5672-86. PubMed ID: 9312026
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mad3 and Mad4: novel Max-interacting transcriptional repressors that suppress c-myc dependent transformation and are expressed during neural and epidermal differentiation.
    Hurlin PJ; Quéva C; Koskinen PJ; Steingrímsson E; Ayer DE; Copeland NG; Jenkins NA; Eisenman RN
    EMBO J; 1995 Nov; 14(22):5646-59. PubMed ID: 8521822
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Repression of Myc-Ras cotransformation by Mad is mediated by multiple protein-protein interactions.
    Koskinen PJ; Ayer DE; Eisenman RN
    Cell Growth Differ; 1995 Jun; 6(6):623-9. PubMed ID: 7669717
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The tumor suppressor KLF11 mediates a novel mechanism in transforming growth factor beta-induced growth inhibition that is inactivated in pancreatic cancer.
    Buck A; Buchholz M; Wagner M; Adler G; Gress T; Ellenrieder V
    Mol Cancer Res; 2006 Nov; 4(11):861-72. PubMed ID: 17114344
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The transcriptional repressor gene Mad3 is a novel target for regulation by E2F1.
    Fox EJ; Wright SC
    Biochem J; 2003 Feb; 370(Pt 1):307-13. PubMed ID: 12444919
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Repression of the human immunodeficiency virus type-1 long terminal repeat by the c-Myc oncoprotein.
    Stojanova A; Caro C; Jarjour RJ; Oster SK; Penn LZ; Germinario RJ
    J Cell Biochem; 2004 May; 92(2):400-13. PubMed ID: 15108364
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mad1 is a transcriptional repressor of Bcl-6.
    Lee SC; Bottaro A; Chen L; Insel RA
    Mol Immunol; 2006 May; 43(12):1965-71. PubMed ID: 16423395
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gene-target recognition among members of the myc superfamily and implications for oncogenesis.
    O'Hagan RC; Schreiber-Agus N; Chen K; David G; Engelman JA; Schwab R; Alland L; Thomson C; Ronning DR; Sacchettini JC; Meltzer P; DePinho RA
    Nat Genet; 2000 Feb; 24(2):113-9. PubMed ID: 10655054
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.